Article
Impact of IL-6 rs1800795 and rs1800796 polymorphisms on clinical outcomes of COVID-19: a study on severity of disease in Turkish population.
Mammalian genome : official journal of the International Mammalian Genome Society - 1 Mar 2025
Cekin Nilgun, Akin Seyda, Pinarbasi Ergun, Doğan Okan Halef
Abstract excerpt
Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is exacerbated by cytokine storms, leading to severe inflammation. Interleukin-6 (IL-6) plays a critical role in this process, and variations in its promoter may influence disease severity. This study aims to investigate the relationship between IL6 promoter polymorphisms rs1800795 (G > C) and rs1800796 (G > C)...
Topics
- Humans
- COVID-19
- Turkey
- Interleukin-6
- Male
- Female
